MLH1 and colorectal carcinoma: Methylation of the MLH1 promoter and BRAF V600E mutations are frequently detected in sporadic MSI-H CRCs but not in patients with Lynch syndrome, suggesting that testing for BRAF mutations and MLH1 promoter methylation may help differentiate Lynch syndrome from sporadic MSI-H/dMMR CRC (115–117).